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Abstract We developed a tissue culture incubator that
can continuously irradiate cells with far-infrared radiation
(FIR) of wavelengths between 4 and 20 lm with a peak of
7–12 lm, and found that FIR caused different inhibiting
effects to five human cancer cell lines, namely A431
(vulva), HSC3 (tongue), Sa3 (gingiva), A549 (lung), and
MCF7 (breast). Then, in order to make clear the control
system for the effect of FIR, the gene expression concerned
to the inhibition effect by FIR were analyzed. In conse-
quence, basal expression level of HSP70A mRNA was
higher in A431 and MCF7 cells than in the FIR-sensitive
HSC3, Sa3, and A549 cells. Also, the over expression of
HSP70 inhibited FIR-induced growth arrest in HSC3 cells,
and an HSP70 siRNA inhibited the proliferation of A431
cells by irradiation with FIR. These results indicate that the
effect of a body temperature range of FIR suppressing the
proliferation of some cancer cells is controlled by the basal
expression level of heat shock protein (HSP) 70A. This
finding suggested that FIR should be very effective medical
treatment for some cancer cells which have a low level of
HSP70. Still more, if the level of HSP70 in any cancer of a
patient was measured, the effect of medical treatment by
FIR can be foreseen for the cancer.
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Introduction
Far-infrared radiation (FIR), which causes heating, includes
electromagnetic waves with wavelengths between 4 and
1,000 lm. Recently, there have been many studies of the
effects of FIR on health and in the preservation of food. The
available evidence indicates that whole-body irradiation by
FIR has many biological effects. For example, hyperther-
mia (body temperature of 39–41C) induced by whole-body
FIR has been reported to substantially inhibit spontaneous
mammary tumor growth in mice [1–4]. At normal temper-
ature ranges (approximately 25.5C), tumor growth in SHN
mice can be inhibited by FIR [5, 6]. Furthermore, whole-
body FIR irradiation is believed to improve human health
and sleep by enhancing blood circulation in the skin [7, 8].
This is likely due to the ability of organic matter to absorb
FIR at wavelengths between 7 and 12 lm.
The effects of FIR, and particularly whole-body FIR,
remain unclear, because the experiments are easily affected by
environmental changes in temperature and humidity and by the
presence of bacteria. Therefore, we developed a chamber for
raising animals that emits FIR upon heating and is capable
of maintaining steady conditions. This system employs a
sealed heater with a carbon/silica/aluminum oxide/titanium
oxide ceramic coating produced using a polycarbonate
printing technique [9]. Using this system, we found that FIR
inhibits tumor growth in the A431 tumor genesis model mouse
by inhibiting the expression of matrix metalloprotease-1, 9,
10, and 13. Recent in vitro studies by Teraoka et al. found that
FIR at wavelengths between 4 and 16 lm inhibits the growth
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of HeLa cells in vitro at 37C [10]. Despite these findings, the
molecular mechanism by which FIR affects cellular gene
expression remains unclear.
The lack of data on the effects of FIR on cells is due to
the difficulty in stably irradiating cells with FIR under ideal
culture conditions (i.e., 100% humidity, 37.0 ± 0.5C, 5%
CO2) and examining the effects of FIR at the cellular level.
Therefore, using a polycarbonate printing technique, we
developed a CO2 incubator with a sealed heater that has a
carbon/silica/aluminum oxide/titanium oxide ceramic
coating and emits FIR upon heating [11]. This CO2 incu-
bator can stably emit FIR at wavelengths between 4 and
20 lm (maximum at 7–12 lm) under conditions of 100%
humidity, 37.0 ± 0.5C, and 5% CO2. Our results using
this incubator indicate that a body temperature range of
FIR radiation suppresses the proliferation of HSC3, Sa3,
and A549 cells. But, A431and MCF7 was not affected.
These differences may be caused by any control system
competing with FIR.
Therefore, the gene expression concerning to the effect
of inhibition by FIR are analyzed in the present study. Still
more, the effect of over expressing and suppressing can-
didate FIR response genes HSP70 we examined.
Materials and methods
FIR incubator
As previously reported [11], we fabricated an FIR radiant-
panel incubator by coating a carbon/silica/aluminum oxide/
titanium oxide ceramic (radiation efficiency [ 97%) using
a polycarbonate printing technique (Bloodissue Co. Ltd.
Tokushima, Japan). The incubator has a stably irradiate
system with FIR at wavelengths between 4 and 20 lm
(maximum at 7–12 lm) under conditions of 100%
humidity, 37.0 ± 0.5C, and 5% CO2 in air.
Calculation of FIR absorbed per 10-cm tissue culture
dish in the FIR incubator
Fourier Transform Infrared Spectroscopy (FTIR) analysis
revealed that the ceramics coating inside the CO2 incubator
emits FIR at 4 W m-1 str-1 lm-1 at wavelengths between
4.486 and 20.256 lm, with a maximal emission of 11.6 W
m-1 str-1 lm-1 at 9 lm, which is [95% of the emission
rate of an ideal black body. Since the ceramic coating was
maintained at 40C, the total generating energy, integrated
over the entire range of wavelengths, was calculated to be
130.225 Wm-2 str-1. The total area of the FIR-emitting
ceramic surface was 1.2385 (m2). Therefore, the total
energy emitted into the incubator was 161.28366 W/str.
Assuming that FIR is emitted in all directions, the total
emission was 2026.7502 J/sec. Given that the volume of
the CO2 incubator was 0.1257 m
3 and the volume of cul-
ture medium was 6 ml, the amount of energy absorbed by
each 10-cm culture dish was 0.09674 J/sec. The surface
area of each 10-cm culture dish was 78.5 cm2, so that the
energy reaching the base of the dish was 0.001232 J/sec/
cm2. Thus, over a 1-h period 4.4352 J/h cm2 was absorbed
by each 10-cm culture dish.
Cell lines and cell culture
A431 human epithelial vulva carcinoma cells and Sa3
human gingival squamous carcinoma cells were purchased
from RIKEN Cell Bank (Tsukuba, Japan). A HSC3 human
tongue squamous carcinoma cells, A549 human lung car-
cinoma cells, and MCF7 human breast carcinoma cells
were purchased from Health Science Research Resources
Bank (Sennan, Japan). A431, A549, and MCF7 cells were
cultured in Dulbecco’s modified Eagle’s medium/Ham’s F-
12 nutrient mixture (Sigma, St. Louis, MO, USA). HSC3
and Sa3 cells were cultured in Eagle’s basal medium
(Sigma). All culture medium was supplemented with 10%
heat-inactivated fetal bovine serum, 100 lg/ml penicillin
G, 100 lg/ml streptomycin sulfate, and 250 ng/ml
amphotericin B (Invitrogen, Carlsbad, CA, USA). Cells
were maintained at 37C in a humidified atmosphere of 5%
CO2 in air. The medium were replaced every 2 days.
Measurement of cell number and growth
Cells (5 9 104) were plated in triplicate in 24-well plates
(Nunc, Roskilde, Denmark). The attached cell populations
were measured on day 8 using 0.2% Trypan blue and a
hemocytometer. Incorporation of 5-bromo-20-deoxyuridine
(BrdU) was used to determine the amount of DNA syn-
thesis. DNA synthesis by proliferating cells was assessed
using a BrdU labeling and detection kit III (Roche,
Mannheim, Germany) according to the manufacturer’s
protocol. Briefly, cells (5 9 103 per well) were seeded in
96-well tissue culture plates (Nunc) and then placed in the
FIR incubator for 4 days, and BrdU incorporation was
measured during the logarithmic growth phase (i.e., before
the cells were confluent) by treating the cells for 4 h at
37C with 10 lM BrdU. BrdU incorporation was quanti-
fied by measuring the absorbance of the substrate reaction
(405 nm) and the absorbance at the reference wavelength
(590 nm) using an ImmunoMini NJ-2300 (System Instru-
ments, Tokyo, Japan). Absorbance values directly
correlated with the amount of DNA synthesis and therefore
the number of proliferating cells.
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Histochemistry
Cells were grown on 22-mm2 glass coverslips in 6-well
culture dishes (Nunc). After 4 days of FIR irradiation, the
cells were observed with a CK40 phase contrast micro-
scope (Olympus, Tokyo, Japan), fixed, and stained with
hematoxylin and eosin. For immunofluorescent staining of
heat shock protein (HSP) 70, cells were washed in Phos-
phate Buffered Saline (PBS), fixed for 20 min in 4%
paraformaldehyde in PBS, washed three times for 5 min
each in PBS, and blocked for 1 h at room temperature with
5% goat serum. Cells were incubated at 4C overnight in
1:200 mouse monoclonal antibody to HSP70 (Stressgen,
Victoria, Canada) in PBS containing 1 mg/ml bovine
serum albumin. After washing, the cells were incubated
with 1:400 FITC (Fluorescein isothiocyanate)-labeled goat
anti mouse IgG (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). The localization of intracellular HSP70 protein
was identified using a BX51 confocal microscope (Olym-
pus) and a Cool SNAP CF digital camera (Roper Scientific,
Trenton, NJ, USA) and calibrated using RS Image Express
software (Roper Scientific).
Microarray studies and data analysis
Four days after FIR irradiation, two control and two FIR-
irradiated samples were prepared for microarray hybridiza-
tion. Total RNA was extracted using a Qiagen RNeasy Mini
Kit (Qiagen, Valencia, CA, USA) according to the manu-
facturer’s protocol. Agilent human 1A ver.2 microarray slides
(Agilent Technologies, Palo Alto, CA, USA) were used for
the hybridization. The quality of RNA samples was moni-
tored using an Agilent 2100 bioanalyzer (200 ng each). To
produce labeled cRNA (complementary RNA), high-quality
RNA was amplified and labeled with Cy5-and Cy3-CTP
(Amersham Biosciences, Buckinghamshire, UK) using a Low
RNA Input Fluorescent Linear Amplification Kit (Agilent)
according to the manufacturer’s protocol. After the amplifi-
cation and labeling, the dye incorporation ratio was
determined using a Nanodrop spectrophotometer, and the
ratios were within 10–20 pmol per lg cRNA, which is the
range suggested by the manufacturer for hybridization. For
hybridization, an Agilent 60-mer oligo microarray (Rev. 7,
SSC Wash/6-screw hybridization chamber) was used
according to the manufacturer’s protocol. Briefly, 750 ng
Cy3-labeled control and 750 ng Cy5-labeled MPP+-treated
sample were mixed and incubated for 17 h with an SSC-
washed microarray slide from an Agilent In situ Hybridiza-
tion Kit. Sample pairs were dye-swapped and processed at the
same time. The washed slides were immediately dried under a
stream of ultrapure N2 in an ozone-free atmosphere. After
drying, the slides were scanned using an Agilent
Technologies Microarray Scanner with the PMT setting at
770 for Cy5 and 670 for Cy3, and the raw data were nor-
malized and analyzed using GeneSpring 7.0 software (Silicon
Genetics, Santa Clara, CA, USA). For normalization, per spot
and per chip intensity-dependent (LOWESS) normalization
was used to correct for the intensity-dependent ratio bias12. In
addition, the following filters were applied to improve the
quality of the data: eliminate saturated signal, eliminate non
uniformity of background, eliminate non uniformity of
feature, Feature Population Outlier, eliminate low-signal
feature of background signal + 2.6 9 SD, and eliminate
P-value\ 0.01. Genes were further classified for process
and function according to their GO term information
(http://www.godatabase.org).
Stable transfection of HSP70A
The HSP70A expression vector pcDNA3-HSP70A con-
taining the cDNA for full-length human HSP70A was a
generous gift from Dr. Hector R. Wong (Children’s Hos-
pital Medical Center, Cincinnati, OH, USA). HSP70A
cDNA was subcloned into the Xba I and Bam HI sites of
pcDNA3.1(-) (Invitrogen). Cells grown on 60-mm dishes
were transfected with 8 lg of pcDNA3-HSP70A, or
pcDNA3.1 (Invitrogen) using Lipofectamine 2000 (Invit-
rogen) according to the manufacturer’s instructions. The
transfected cells were selected with 400 lg/ml G418
(Sigma), and clones formed were collected and maintained
separately in medium supplemented with 400 lg/ml G418.
Reverse transcription (RT)-polymerase chain
reaction (PCR)
Total RNA was extracted using Trizol reagent (Invitrogen)
following the manufacturer’s instructions. The concentration
and purity of the RNA were determined spectrophotometri-
cally. One microgram of total RNA was reverse-transcribed
into first-strand cDNA. Next, oligo(dT12–18) primer (Invitro-
gen), 10 mM dNTP mix (Invitrogen), 25 mM MgCl2
(Promega, Madison WI, USA), and 0.1 M dithiothreitol
(Invitrogen) were added, and the mixture was incubated for
2 min at 42C. Next, the RT reaction was performed by
adding SuperScript II RT (Invitrogen) and incubating at 42C
for 50 min, followed by 70C for 15 min. The reaction was
terminated by rapid cooling on ice, after which RNA in the
sample was degraded by treatment with RNase H (Invitrogen)
at 37C for 20 min. Polymerase chain reaction (PCR) was
carried out using a 1-ll sample of the RT reaction and Ready
Mix PCR Master Mix (AB gene, Epsom, Surrey, UK).
The analyzed genes and the respective primer sequences
were as follows: HSP70A, 50-TGTTCCGTTTCCAGCCCC
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CAA-30 (sense) and 50-GGGCTTGTCTCCGTCGTTGAT-30
(antisense); HSP70B, 50-CTCCAGCATCCGACAAGAA
GC-30 (sense) and 50-ACGGTGTTGTGGGGGTTCAGG-30
(antisense); HSP70C, 50-TTGAGGAGGTGGATTAGGGGC-
30 (sense) and 50-AGCCTTTGTAGTGTTTTCGCC-30 (anti-
sense); glyceraldehyde-3-phosphate dehydrogenase (G3PDH),
50-ACCACAGTCCATGCCATCAC-30 (sense) and 50-TCCA
CCACCCTGTTGCTGTA-30 (antisense). PCR was carried out
using cycles (30 for HSPs and 23 for G3PDH) of 94C for 45 s,
58C for 30 s (all HSPs) or 52C (G3PDH), and 72C for 90 s.
Finally, primer extension was performed for 10 min at 72C. A
10-ll sample of each PCR product was separated by electro-
phoresis on a 1.5% polyacrylamide gel in Tris borate/EDTA
buffer and stained with ethidium bromide.
Quantitative real-time RT-PCR data analysis
To determine the level of HSP70A mRNA, quantitative
real-time RT-PCR was carried out using a LightCycler and
the Fast Start DNA Master SYBR Green I Kit (Roche). The
reaction contained 50 ng of cDNA and 100 pmol of each
primer in a final volume of 10 ll. The gene-specific
primers were as follows: HSP70A, 50-TGTTCCGTTT
CCAGCCCCCAA-30 (sense) and 50-GGGCTTGTCTCC
GTCGTTGAT-30 (antisense); and a-actin, 50-ATAGCA
CAGCCTGGATAGCAACGTAC-30 (sense) and 50-CACC
TTCTACAATGAGCTGCGTGTG-30 (antisense). The
concentration of Mg2+ was 3 mM. In all cases, a first phase of
denaturation was performed at 95C for 10 min. Amplifica-
tion was carried out for cycles of denaturation at 95C for
10 s, hybridization for 10 s (58C for HSP70A or 60C for a-
actin), and elongation at 72C (20 s for HSP70A or 10 s for
a-actin). Product specificity was evaluated by melting curve
analysis. Fluorescence data were analyzed using LightCycler
Software Ver. 3.5 (Roche). Crossing points were established
using the second derivative method. The relative amount of
target transcript in the sample was calculated by dividing the
amount of target by the amount of internal standard (a-actin).
Results were expressed as the target/internal standard con-
centration ratio calculated from the calibration curve. Since
the target and internal standard genes had different sequence
and amplicon lengths, it was expected that they would show
different PCR efficiencies. Therefore, the PCR efficiency
(10-1/m, where m is the slope from the calibration curve) was
first established for each pair of primers. All reactions were
performed in triplicate.
HSP70 Enzyme-Linked Immuno Sorbent Assay
(ELISA)
HSP70 protein was quantified in cell lysates using a
commercially available ELISA kit for human HSP70
(Stressgen). Cells (105 per well) were seeded in 6-well
plates (Nunc). After 4 days, the cells were lysed, and all
samples were assayed at optimal dilutions according to the
manufacturer’s instructions.
Protein extraction and Western blotting
Cells (1 9 106) were grown in 60-mm tissue culture dishes
(Nunc). After removing the cell culture medium from the
culture dishes (Nunc) and washing the cells twice with cold
PBS(-), the cells were lysed in lysis buffer (20 mM Tris–
HCl, pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1% Triton
X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycero-
phosphate, 1 mM Na3VO4, and 1 lg/mL leupeptin).
Protein levels were measured by the Lowry method [13]
using a DC Protein Assay Kit (Bio-Rad, Hercules, CA,
USA). Cell lysate containing 15 lg of protein for HSP70
was subjected to Sodium Dodesyl Sulfate (SDS)-poly-
acrylamide gel electrophoresis. Separated proteins were
then transferred from the gel to a polyvinylidene difluoride
membrane. After blocking with 5% skim milk in PBS-
Tween, the membrane was incubated for 1 h at room
temperature with primary antibody in PBS-T containing
5% skim milk, followed by three 10-min washes with PBS-
T. Next, the membranes were incubated for 1 h at room
temperature with horseradish peroxidase-labeled secondary
antibody and washed three times for 10 min with PBS-T.
Immunoreactive protein was detected using an ECL plus
kit (Amersham Biosciences) and visualization by exposure
to Hyperfilm (Amersham Biosciences). The primary anti-
bodies used were rabbit anti-HSP70 (Stressgen), anti a-
actin (Sigma), and the secondary antibody was horseradish
peroxidase-conjugated anti-mouse (Zymed Laboratories,
South San Francisco, CA, USA) or anti-rabbit IgG
(Amersham Biosciences).
Small interfering RNA (siRNA)
We designed 21-nucleotide siRNAs targeting human
HSP70A and HSP70C according to the manufacturer’s
instructions (Dharmacon, Lafayette, CO, USA) and corre-
sponding to the sequence 50-AAGAACCAGGUGGCG
CUGAAC-30. It was not possible to design a siRNA
specific to HSP70A because its mRNA was highly homol-
ogous to the mRNA for HSP70C (see Table 1). We used
siCONTROL Non-Targeting siRNA (Dharmacon; 50-UA-
GCGACUAAACACAUCAAUU-30) as a negative control
because it does not match the sequence of any known
human or mouse genes. Cells (1 9 104/well) were plated in
96-well culture dishes (Nunc) and cultured for 24 h at 37C
in a 5% CO2 atmosphere. When the cells reached 70–90%
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confluence, they were transfected with 100 nM siRNAs to
HSP70A and HSP70C or control siRNAs complexed with
Lipofectamine 2000 (Invitrogen) according to manufac-
turer’s instructions. The growth medium was removed after
6 h, and the culture dish was transferred to the FIR incu-
bator. After incubation for 48 h at 37C in a 5% CO2
atmosphere, cell proliferation was assessed by BrdU
incorporation.
Statistical analysis
Data are means ± SE of replicate samples in single
experiments or replicate experiments as described in the
figure legends. Student’s t-test was used for comparisons
between two groups. Multiple group comparisons were
performed by one-way ANOVA, followed by the Tukey–
Kramer multiple group comparisons test. All statistical
analyses were performed using Statcel 2 software (OMS
publishing, Saitama, Japan).
Results
FIR irradiation selectively inhibits the growth of
specific cancer cell lines
To clarify the effect of FIR irradiation on the proliferation
of cancer cell lines, we irradiated five cancer cell lines
(A431, HSC3, Sa3, A549, and MCF7) with FIR and
measured the number of live cells by Trypan blue dye
exclusion. Although the proliferation of HSC3, Sa3, and
A549 cells were significantly suppressed on day 8 of cul-
ture (45.75%, 74.63%, and 65.79%, respectively), FIR
irradiation had little effect on the growth of A431, or
MCF7 cells (Fig. 1).
Microarray analysis and extraction of candidate gene
for FIR control
Several gene families showed high correlations between
endogenous expression (signal in the microarray) and the
growth rate, proteins involved in cell proliferation, cyto-
skeletal proteins, cell cycle components, and protein
kinases. Especially, in the analysis of stress factor, some
genes encoding the HSPs which were well known that they
participate in the cellular resistance to stress were focused.
Of the 35 HSP genes on the microarray, HSP70 showed the
highest correlation with the growth rate (Fig. 2a, b). We
examined this further by real time RT-PCR, and we found
that HSP70 is most highly expressed in A431 cells at all
stages of the cell cycle. Lower levels of expression were
found in HSC3 and Sa3 cells (Fig. 2c). We did not find a
statistically significant difference between the expression
of this gene between control (unirradiated) and FIR-irra-
diated A431, HSC3, or Sa3 cells. An ELISA for HSP70 in
untreated cells showed similar results, specifically, that the
expression of HSP70A was higher in A431 cells than in the
HSC3 or Sa3 cells (Fig. 2d).
Increased expression of HSP70A improves the survival
of HSC3 cells after a limited exposure to FIR
To directly determine whether HSP70 can protect cells
from FIR-induced cell death, we developed A431 and
HSC3 cell lines stably expressing human HSP70A (A431-
HSP70A and HSC3-HSP70A cells, respectively). Control
cells were transfected with empty pcDNA3.1 (A431-Neo
and HSC3-Neo; Fig. 3a, b). In our initial experiments, we
found that exposure of HSC3 and Sa3 cells but not A431
Table 1 Characterization of
Hsp70 (A, B, and C)
a Percent amino acid homology
to the HSP70 protein coded by
Hsp70A





Hsp70A n6p21.3 100 100 HSPA1A, Hsp72, Hsp70-1a M11717
Hsp70B lq23 84 84 HSPA6, Hsp70B X51757
Hsp70C 6p21.3 99 98 HSPA1B, Hsp72, Hsp70-1b M5980
Fig. 1 Effect of FIR irradiation on cell growth of five cancer cell
lines. Cells (1 9 105) were plated in 24-well dishes and cultured for
8 days. Cell numbers were counted every other day. Although
proliferation of HSC3, Sa3, and A549 cells was suppressed on day 8
of culture, FIR irradiation had little effect on the proliferation of A431
and MCF7 cells. *P \ 0.05 vs. unirradiated control cells
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cells to limited FIR causes G2/M arrest and induces partial
hypertrophy to necrosis (data not shown). To determine
whether increased expression of HSP70A confers protec-
tion against FIR, cell survival was examined in FIR-
irradiated A431-HSP70, A431-Neo, A431-wt, and HSC3-
HSP70, HSC3-Neo, and HSC3-wt cells. We found that
over expression of HSP70A increased cell proliferation in
A431 and HSC3 cells. Furthermore, the proliferation of
FIR-irradiated and control (unirradiated) A431-HSP70A
cells was similar (Fig. 3c). The survival rate after 6 days of
FIR irradiation was significantly higher in HSC3-HSP70A
cells than in HSC3-Neo or HSC3-wt cells. In addition, the
proliferation of FIR-treated HSC3-HSP70A cells was
similar to that of control HSC3-HSP70A cells. BrdU
incorporation was significantly higher in FIR-irradiated
or control A431-HSP70A cells than in A431-Neo or
A431-wt cells (Fig. 3d). Although BrdU incorporation of
FIR-irradiated HSC3-wt and HSC3-Neo cells was lower
than in unirradiated HSC3-wt and HSC3-Neo cells, it was
similar in FIR-irradiated and unirradiated HSC3-HSP70A
cells. Surprisingly, BrdU incorporation by HSC3-HSP70A
cells was significantly higher in both FIR-irradiated and
unirradiated cells. These data demonstrate that over
expression of HSP70A in HSC3 and A431 cells did not
affect their proliferation, and also their morphology, even
when they were irradiated with FIR (Fig. 3e).
Knocking down HSP70A by using siRNA improves the
deth of HSC3 cells after a limited exposure to FIR
We next examined the effect of knocking down HSP70A
and HSP70C mRNA and HSP70 protein expression using
siRNA. Transfection with HSP70A/C siRNA effectively
Fig. 2 Relationship between
the expression of HSP70 and the
suppression of proliferation by
FIR irradiation. (a) Correlation
between the signal from the
microarray for the HSP family
members in the control group
and the correlation coefficient.
(b) Correlation between the
signal from the microarray for
HSP70 and the growth rate in
the control and the FIR-treated
cells. (c) Expression of HSP70A
mRNA in A431, HSC3, and Sa3
cells after 0.5, 1, 2, 4, 8, and
12 days of culture. The level of
these mRNAs was determined
by quantitative real-time RT-
PCR. Bars represent the means
and error bars the SD from three
independent experiments. (d)
Level of HSP70 protein on day
4 of culture. The concentration
of HSP70 protein was measured
by ELISA. Bars represent the
mean, and error bars the SD
(n = 4). *P \ 0.01 vs. to A431
cells
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decreased HSP70A and HSP70C mRNA (Fig. 4a) and
protein levels (Fig. 4b) in both A431 and HSC3 cells
without affecting the level of HSP70B mRNA or protein.
HSP70A/C siRNA did not suppress BrdU incorporation in
unirradiated A431 cells, but it suppressed BrdU incorpo-
ration in cells irradiated with FIR (Fig. 4c). Similarly, the
HSP70A/C siRNA enhanced the suppression of BrdU
incorporation by FIR irradiation. FIR irradiation also
Fig. 3 Over expression of
HSP70 prevents the suppression
of cell growth and induction of
cell hypertrophy by FIR. (a)





increased expression of HSP70
in stably transfected A431 and
HSC3 cells. Lane 1, wild-type
cells; lane 2, cells transfected
with empty pcDNA3.1(+); lane
3, cells transfected pcDNA3.1-
HSP70A. (c) Cell proliferation
of empty vector-transfected and
HSP70-overexpressing cells.
Cell proliferation was the same
in FIR-irradiated and untreated
A431 cells overexpressing
HSP70. In contrast, in HSC3
cells, over expression of HSP70





treated with FIR. (e)
Hematoxylin and eosin staining
of wild-type, empty vector-
transfected, and HSP70A-
overexpressing A431 and HSC3
cells after 5 days of
transfection. Note that the
morphology of HSP70A-
transfected HSC3 cells was
unaffected by FIR irradiation
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significantly suppressed BrdU incorporation in HSC3 cells
transfected with the negative control siRNA (Fig. 4c).
These results indicate that a decrease in HSP70 protein
mediates the ability of limited FIR to inhibit the prolifer-
ation of A431 and HSC3 cells.
Discussion
In the present studies, we showed that FIR suppresses the
proliferation of HSC3, Sa3, and A549 cell lines. Two other
cell lines, A431 and MCF7, showed almost no growth
arrest in response to FIR. The effect of FIR does not seem
to be related to the cell type or source, because these three
cell lines have different origins: HSC3 is from a tongue
squamous cell carcinoma, Sa3 is from a gingival squamous
cell carcinoma, and A549 is from a pulmonary adenocar-
cinoma. FIR was found to cause hypertrophy without
apoptosis in all three sensitive cell lines, although there
was a slight increase in necrosis in the Sa3 cells by his-
tological observation. In addition, the expression of
apoptosis-related genes was unchanged in the FIR-sensitive
cells by microarray analysis. Overall, FIR seemed to cause
changes in the cytoskeleton, suppress proliferation, and
induce some necrosis without apoptosis. These results raise
the question of why proliferation of A431 and MCF7 was
not suppressed by FIR. Perhaps something in certain cancer
cell lines is present for resistance to FIR. We then focused
on genes encoding the HSPs, which are well known to
participate in the cellular resistance to stress. We found that
HSP70 showed the highest correlation with the growth rate
of cancer cells affected by FIR in 35 HSP genes on the
microarray system.
The expression of HSP70A mRNA was higher in FIR-
insensitive A431 and MCF7 cell lines than in FIR-sensitive
HSC3, Sa3, and A549 cell lines, although the gene
expressions were not induced by FIR. This finding was
confirmed by analysis of the expression of HSP70 mRNA
and protein with real-time reverse transcription-polymerase
chain reaction and enzyme-linked immunosorbent assay.
These results suggested that the effect on body temperature
range by FIR, suppressing the proliferation of some cancer
cells, may be controlled by the basal expression level of
HSP70A. To test this hypothesis, the effects of overex-
pression and suppression of the HSP70 gene were studied.
As a result, the overexpression of HSP70 inhibited FIR-
induced growth arrest in HSC3 cells and an HSP70 siRNA
inhibited the proliferation of A431 cells by FIR. These
results confirmed that the effect on body temperature range
by FIR, suppressing the proliferation of some cancer cells,
is controlled by the basal expression level of HSP70A.
HSP70 appears to be present in a variety of normal cell
types and its expression may be induced by several
stressors, such as hyperthermia, cardiac ischemia, infec-
tion, UV radiation, endotoxin, and nitric oxide to suppress
or denature any foreign protein and restore an injured
protein from lethal effects [12]. HSP70 seems to be par-
ticularly important for cancer cells. In human breast cancer,
the expression of HSP70 correlates with increased cell
proliferation, poor differentiation, lymph node metastases,
and poor therapeutic outcome [13]. In vivo animal studies
and clinical trials have revealed that hyperthermia may
serve as a powerful tool in the treatment of prostate cancer
[14–19]; at the cellular level, hyperthermic stress induces
HSPs. Moreover, chemotherapeutic agents such as cis-
platin, adriamycin, and bleomycin, as well as c-radiation
induce HSPs. HSP70 participates in cytoprotection and is
associated with cellular resistance to lethal external effects
[17–20]. However, in the present study, HSP70 was never
Fig. 4 Inhibition of HSP70 expression and BrdU incorporation in
A431 and HSC3 cells after 48 h of transfection with 100 nM HSP70
siRNA. (a) RT-PCR of HSP70A, HSP70B, and HSP70C in A431 and
HSC3 cells after treatment with siRNAs. C, wild-type control cells;
NC, cells transfected with negative control siRNA; siRNA, cells
transfected with HSP70-siRNA. (b) Western blot analysis of HSP70
protein expression in A431 and HSC3 cells. The lanes are as shown in
panel A. (c) Inhibition of HSP70 suppressed FIR-induced DNA
synthesis in A431 cells. Cells were transfected with 100 nM HSP70
siRNA and grown for 48 h. Bars represent the mean and error bars the
SD (n = 5). *P \ 0.05). In HSC3 cells, the random siRNA slightly
suppressed DNA synthesis, whereas the HSP70 siRNA strongly
suppressed DNA synthesis
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induced by FIR. These results suggested that FIR has anti-
tumor activity without inducing HSP70 as an anti-stress
factor. This characteristic indicates that FIR may be suit-
able for medical treatment.
Neutralization of the function of HSP70 or inhibition of
its expression may inhibit tumor growth and/or sensitize
tumor cells to chemotherapeutic agents without affecting
normal cells. Furthermore, inhibition of HSP70 expression
reduces cell survival. Conversely, microinjection of an
HSP70-neutralizing antibody increases the vulnerability of
cells to damage by sub-lethal temperatures [21, 22]. This
finding was consistent with our results for FIR and the
suggestion of HSP70 as the acting mechanism. However,
FIR may be regarded as a sub-lethal stress that avoids an
anti-stress reaction in some cancer cells.
This is the first report suggesting that HSP70 may not
rescue cells from the effects of FIR, although HSP70 is
known to rescue cells from tumor necrosis, factor-induced
caspase-independent programed cell death, heat shock,
serum starvation, and oxidative stress [23]. This finding
suggests that the effect of FIR may be a sub-lethal stress for
cancer cells protected by HSP70 as an anti-stress protein.
In other words, FIR may be a very effective medical
treatment for some cancer cell lines that have a low level of
HSP70. Furthermore, if the level of HSP70 in any cancer of
a patient is measured, the effect of medical treatment by
FIR on the cancer may be predicted.
Conclusion
It was found here for the first time the effect on body
temperature range by FIR in several cancer cell lines in
vitro, which is controlled by endogenous HSP70 to protect
cells from FIR-induced growth arrest. This finding suggests
that FIR may be a very effective medical treatment for
some cancer cell lines that have a low level of HSP70.
Furthermore, if the level of HSP70 in any cancer of a
patient is measured, the effect of medical treatment by FIR
on the cancer may be predicted.
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